Global epidemiology and genetic evolution of enterovirus D68 over a decade (2015–24): a systematic review
The Lancet Microbe · 2026-11 · 101570
DOI: 10.1016/j.lanmic.2026.101570 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Lancet Microbe, 2026-11. Verfasst von Aurora Hirvonen und 5 weiteren Autor:innen. Beteiligte Einrichtung: National PhD Programme in One Health approaches to infectious diseases and life science research, Department of Public Health, Experimental and Foren…. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Enterovirus D68 (EV-D68) is a persistent global health concern, causing mild to severe respiratory disease and, in rare cases, acute flaccid myelitis, a polio-like paralytic syndrome. In this systematic review, we synthesised global data on the epidemiology and genetic evolution of EV-D68 from 2015 to 2024 and show its continued widespread circulation and concerning severity. 8184 EV-D68 cases were reported by 44 countries, and 267 (3·3%) of these cases were EV-D68-associated acute flaccid paralysis cases reported by 26 countries, across all continents. Biennial upsurges followed a distinct every-even-year pattern until 2020, after which the circulation showed geographical diversification in Europe and North America, possibly influenced by the COVID-19 pandemic. EV-D68 remained associated with severe respiratory disease and acute flaccid myelitis, not only primarily in children younger than five years but also increasingly in adults. Individuals who progressed to acute flaccid paralysis had poor prognosis for full recovery. Genotypic shifts were marked by the dominance of subgenotype B3 since 2016 and A2/D since 2018, with novel variants emerging for both after 2020. Despite limitations in surveillance quality and coverage, the findings underscore the need for sustained surveillance, improved diagnostic strategies, and targeted interventions to mitigate EV-D68-related morbidity.
Autor:innen und Institutionen
- National PhD Programme in One Health approaches to infectious diseases and life science research, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.
- Research Department, Swiss Tropical and Public Health Institute, Allschwil, Switzerland; University of Basel, Basel, Switzerland; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
- Department of Clinical Research, Nordsjællands Hospital, Hillerød, Denmark.
- Department of Clinical Research, Nordsjællands Hospital, Hillerød, Denmark; PandemiX Center of Excellence (DNRF170), Roskilde University, Roskilde, Denmark; Department of Public Health, University of Copenhagen, Copenha…
- Microbiology Services, NHS Blood and Transplant, London, UK; Institute of Biomedicine, University of Turku and University Hospital Turku, Turku, Finland; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Depa…
- Centre for Infectious Disease Research, Diagnostics and Laboratory Surveillance, National Institute for Public Health and the Environment, Bilthoven, Netherlands. Electronic address: kim.benschop@rivm.nl.
Zitieren
APA
Hirvonen, A., Hodcroft, E. B., Johannesen, C. K., Fischer, T. K., Harvala, H., & Benschop, K. S. M. (2026). Global epidemiology and genetic evolution of enterovirus D68 over a decade (2015–24): a systematic review. The Lancet Microbe, 101570. https://doi.org/10.1016/j.lanmic.2026.101570
Vancouver
Hirvonen A, Hodcroft EB, Johannesen CK, Fischer TK, Harvala H, Benschop KSM. Global epidemiology and genetic evolution of enterovirus D68 over a decade (2015–24): a systematic review. The Lancet Microbe. 2026:101570. doi:10.1016/j.lanmic.2026.101570
BibTeX
@article{Hirvonen2026,
author = {Hirvonen, Aurora and Hodcroft, Emma B and Johannesen, Caroline Klint and Fischer, Thea K and Harvala, Heli and Benschop, Kimberley S M},
title = {Global epidemiology and genetic evolution of enterovirus D68 over a decade (2015–24): a systematic review},
journal = {The Lancet Microbe},
year = {2026},
pages = {101570},
doi = {10.1016/j.lanmic.2026.101570}
}
EUVIMED